| Literature DB >> 28298069 |
Jin Li1, Tingting Wang1, Lu Pei1, Junpeng Jing2, Wentan Hu1, Tiange Sun3, Hongchun Liu4.
Abstract
Esophageal cancer is considered one of the most malignant tumors, being characterized by rapid progression and poor outcomes. China has the highest incidence of esophageal cancer in the world. Hence, it is necessary to clarify the mechanisms underlying esophageal cancer progression. In this study, we examined the expression of vaccinia-related kinase 1 (VRK1) and barrier to autointegration factor 1 (BANF1) in tumor tissues at the mRNA and protein levels via real-time PCR and immunohistochemical analyses. The mRNA and protein expression levels of VRK1 and BANF1 were higher in tumor tissues than in adjacent normal tissues. ROC curve analysis showed that VRK1 and BANF1 yielded AUCs of 0.790 and 0.735, respectively, for the detection of esophageal squamous cell carcinoma(ESCC) patients. In conclusion, our study indicates that VRK1 and BANF are promising novel therapeutic targets for esophageal cancer.Entities:
Keywords: Barrier to autointegration factor 1 (BANF1); Esophageal cancer; Vaccinia-related kinase 1 (VRK1)
Mesh:
Substances:
Year: 2017 PMID: 28298069 DOI: 10.1016/j.biopha.2017.02.095
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529